Lv5
1380 积分 2022-08-12 加入
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
13小时前
待确认
Acalabrutinib in treatment-naive chronic lymphocytic leukemia
15小时前
待确认
Determination of olverembatinib in human plasma and cerebrospinal fluid by an LC-MS/MS method: Validation and clinical application
8天前
已完结
Unravelling the CXCL12/CXCR4 Axis in breast cancer: Insights into metastasis, microenvironment interactions, and therapeutic opportunities
10天前
已完结
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
12天前
已完结
Neuropathic pain: Redefinition and a grading system for clinical and research purposes
13天前
已完结
Data from Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
1个月前
已关闭
Data from Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
1个月前
已关闭
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
1个月前
已完结
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
